SCHEMBL7989596

SCHEMBL7989596

COP(=O)(OC)C(CSCC(=O)O)P(=O)(OC)OC

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.41
HIF1A Q16665 1/20 0.41
MVD P53602 1/20 0.35
MAPT P10636 2/20 0.33
GMNN O75496 1/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33
THRB P10828 1/20 0.33
CYP2C9 P11712 1/20 0.33
BLM P54132 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CYP1A2 P05177 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP2C19 P33261 2/20 0.31
LMNA P02545 2/20 0.31
MEN1 O00255 1/20 0.31
TRPA1 O75762 1/20 0.31
KMT2A Q03164 1/20 0.31
BHMT Q93088 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7990050 0.81 CYP2D6 (0.38) CYP2D6HIF1AMVDMAPTGMNN
SCHEMBL7882568 0.81 CYP2D6 (0.38) CYP2D6HIF1AMVDMAPTGMNN
SCHEMBL7998419 0.79 MVD (0.38) CYP2D6HIF1AMVDMAPTGMNN
SCHEMBL8002512 0.76 GMNN (0.42) CYP2D6HIF1AMVDMAPTGMNN
SCHEMBL14796398 0.73 LMNA (0.37) MAPTALDH1A1CYP2C19LMNA
SCHEMBL10978113 0.69 CYP2D6 (0.41) CYP2D6HIF1AMAPTGMNNTP53
SCHEMBL2203031 0.68
SCHEMBL13024935 0.67 CYP2D6 (0.42) CYP2D6HIF1AMAPTGMNNTP53
SCHEMBL4271792 0.66
SCHEMBL3821789 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0944635-A4 DIPHOSPHONATE THERAPEUTIC COMPOUNDS ELIZANOR BIOPHARMACEUTICALS IN (US) 2000-07-05 EP claimed
EP-0944635-A1 DIPHOSPHONATE THERAPEUTIC COMPOUNDS Elizanor Biopharmaceuticals, Inc. (US) 1999-09-29 EP claimed
WO-1998015560-A1 DIPHOSPHONATE THERAPEUTIC COMPOUNDS ELIZANOR BIOPHARMACEUTICALS, INC. (US) 1998-04-16 WO claimed